BioCentury
ARTICLE | Company News

MorphoSys, Novartis deal

February 28, 2011 8:00 AM UTC

MorphoSys received an undisclosed double-digit million Euro milestone payment from Novartis under a 2007 deal that gave Novartis preferred exclusive access to MorphoSys' HuCAL antibody technology. The...